The following article was featured in:
Source:
PhillyVoice
04/02/2026.
The Food and Drug Administration's approval of Eli Lilly's weight-loss pill Foundayo could expand access to GLP-1s, but a Temple University obesity expert said the out-of-pockets prices could still be...
Continue on to full article...
